Last updated on 11 Feb 2021
Owner Info
Apellis Pharmaceuticals, Inc.
100 Fifth Avenue, Third Floor
Attn: Legal Department, UNITED STATES OF AMERICA
Serial Number
2096862 filed on 2 Mar 2020
Correspondent
John V. Hobgood, Esquire Wilmer Cutler Pickering Hale and Dorr LLP
60 State Street,
Boston MA 02109,
UNITED STATES OF AMERICA
2096862
2 Mar 2020
2 Mar 2030
FIGURATIVE, FANCY
13 Sept 2019
US
Status Date | Action Taken |
---|---|
11th Feb 2021 | Amendment to International Registration Contact Requested |
17th Nov 2020 | International Registration in Australia Protected correspondence sent |
16th Nov 2020 | IP Right Registration Published |
16th Nov 2020 | Status change to Registered/Protected |
8th Sept 2020 | Application Accepted correspondence sent |
7th Sept 2020 | IP Right has been Examined |
7th Sept 2020 | IP Right Acceptance Published |
7th Sept 2020 | Status change to Accepted |
18th Jun 2020 | Awaiting examination |
18th Jun 2020 | Examination expedited |